Lotion and tablet for dry, itchy skin
Part of Immune system & allergy, Skin clinical trials.
This study tests a new lotion and tablet combination for treating mild to moderate itching and hives in people with dry or sensitive skin. You'll use the products at home and have regular check-ins to see if they're safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old.
- You should have mild to moderate dry or sensitive skin with itching or hives.
- The area where the lotion is applied must be free of cuts, tattoos, scars, or sunburn.
- You can't be taking daily medicines like allergy pills, anti-inflammatories, or steroids (except birth control).
- You must agree to use only the study products on your skin during the trial and avoid other medicated skincare.
- If you are a woman, you need to use birth control (or be menopausal) and not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using two cosmetic products together helps relieve dry and itchy skin in people with sensitive skin. If you qualify, you may get a new skin care routine that could reduce itching and improve your skin's moisture.
This study tests a new skincare product for people with dry or sensitive skin to see if it is safe and works well. If you join, you will use the product for the study period and have regular check-ups.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
This trial tests a new daily pill called TLL-018 (a JAK inhibitor) for people with chronic hives that still cause symptoms despite taking antihistamines. It aims to see how fast it relieves itching and hives.
This study tests a new oral medication (TLL-018) for people with chronic hives that don't fully go away with standard antihistamines. It aims to see if the drug reduces itching and hives better than placebo.
Hear when a new Dry Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.